1. PTH-058 Golimumab: early experience and medium-term outcomes from two uk tertiary ibd centres. (17th June 2017) Authors: Samaan, MA; Pavlidis, P; Akintimehi, AO; Medcalf, L; Chung-Faye, G; Dubois, P; Koumoutsos, I; Anderson, S; Sanderson, J; Hayee, BH; Irving, PM Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTH-074 The Presence of Total Anti-Drug Antibodies to Biologic Drugs Does not Adversely Affect Long-Term Outcomes in Crohn's Disease Patients with Adequate Drugs Levels and Absent Free Anti-Drug Antibodies. (17th August 2016) Authors: Samaan, MA; Unsworth, N; Ward, M; Warner, B; Sanderson, JD; Arkir, Z; Irving, PM Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTU-062 Vedolizumab: Early Experience and Medium-Term Follow up Data from Two UK Tertiary IBD Centres. (17th August 2016) Authors: Samaan, MA; Pavlidis, P; Johnston, E; Warner, B; Digby-Bell, J; Koumoutsos, I; Fong, S; Goldberg, R; Gulati, S; Medcalf, L; Sastrillo, M; Bedwell, T; Brown-Clarke, C; Bidwell-Sullivan, J; Forsyth, K; Lee, E; Stanton, A; Duncan, J; Chung-Faye, G; Dubois, P Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PTU-065 Four-Way Comparison of Elisa Methods Available for the Measurement of Infliximab and Anti-Infliximab Antibody in IBD Patients. (17th August 2016) Authors: Unsworth, N; Samaan, MA; Warner, B; Arkir, Z; Irving, PM Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PTU-258 Prevalence and severity of pre-pouch ileitis: a distinct disease entity or a manifestation of refractory pouchitis?. (22nd June 2015) Authors: Samaan, MA; de Jong, D; Sahami, S; Morgan, S; Fragkos, K; Subramaniam, S; Kok, K; Makanyanga, J; Barnova, I; Saravanapavan, H; Parisi, I; Di Caro, S; Vega, R; Rahman, F; McCartney, S; Bloom, S; van den Brink, G; Löwenberg, M; Ponsioen, C; Buskens, CJ Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PWE-005 Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease. (8th June 2018) Authors: Birdi, S; Sierra Morales, M; Samaan, MA; Brown-Clarke, C; Stanton, A; Ray, S; Koumoutsos, I; Mawdsley, J; Anderson, S; Sandersdon, ; Irving, PM Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PWE-052 Current practices in ileal pouch surveillance for ulcerative colitis patients in three london ibd referral centres. (17th June 2017) Authors: Samaan, MA; Segal, J; Kabir, M; Morgan, S; Forsyth, K; Elkady, S; Kok, K; Arenaza, AP; Seward, E; Vega, R; Caro, S Di; Mehta, S; Rahman, F; McCartney, S; Bloom, S; Northover, M; Westcott, E; Darakhshan, A; Williams, A; Anderson, S Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗